Elyza vs PostEra
ElyzaGenerative AI Platforms
From ¥980 / user / moPublished price
PostEraDrug Discovery Platforms
CustomPublished price
Elyza Generative AI Platforms Creating the ordinary in uncharted territory | PostEra Drug Discovery Platforms Medicinal Chemistry Powered by Machine Learning | |
|---|---|---|
| Overview | ||
| Category | Generative AI Platforms | Drug Discovery Platforms |
| What it is | Japanese LLM company offering Japanese-language foundation models for enterprises. | AI-powered medicinal chemistry platform that accelerates drug design through synthesis-aware generative chemistry and retrosynthesis. |
| Pricing | ||
| Published price | From ¥980 / user / mo ELYZA Works publishes Standard-plan pricing from ¥980 per light account per month, excluding tax. Basic accounts are ¥2,980 and Premium accounts ¥4,980 per month; a trial plan is… | Custom No public pricing; partnership/collaboration-based. PostEra engages pharma partners under drug-discovery deals (with Pfizer, Amgen and others) rather than a self-serve subscriptio… |
| Pricing model | Custom quote | Custom quote |
| Free options | No free plan · Free trial | No free plan · No free trial |
| Deal on Cubbie | None right now | None right now |
| Company | ||
| Founded | 2018 | 2019 |
| Team size | 51-200 employees | 51-200 employees |
| Headquarters | Tokyo, Japan | Boston, MA |